Title:
Pfizer-BioNTech begin late-stage study of lead COVID-19 vaccine candidate
Authors:
Vishwadha Chander & Carl O'Donnell
Publsihed:
Reuters, 28 July 2020
https://www.reuters.com/article/us-health-coronavirus-pfizer-biontech/pfizer-biontech-begin-late-stage-study-of-lead-covid-19-vaccine-candidate-idUSKCN24S2Q9
From the article:
German biotech BioNTech and U.S. drugmaker Pfizer Inc said on Monday they would begin a pivotal global study to evaluate their lead COVID-19 vaccine candidate.